CD8+ cytotoxic T cells derived from OT-1 mice have been demonstrated to effectively eradicate tumor cells expressing the peptide from chicken ovalbumin-derived peptide (OVA), both in vitro and in vivo. This evidence concerns the gene CD8A and neoplasm.